BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8717183)

  • 21. Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4.
    Han ZC; Maurer AM; Bellucci S; Wan HY; Kroviarski Y; Bertrand O; Caen JP
    J Lab Clin Med; 1992 Oct; 120(4):645-60. PubMed ID: 1402341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
    Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
    Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells.
    Zhang J; Lu SH; Liu YJ; Feng Y; Han ZC
    Leuk Res; 2004 Jun; 28(6):631-8. PubMed ID: 15120941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human megakaryocyte progenitor cells.
    Bruno E; Hoffman R
    Semin Hematol; 1998 Jul; 35(3):183-91. PubMed ID: 9685164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mpl ligand (MGDF) alone and in combination with stem cell factor (SCF) promotes proliferation and survival of human megakaryocyte, erythroid and granulocyte/macrophage progenitors.
    Rasko JE; O'Flaherty E; Begley CG
    Stem Cells; 1997; 15(1):33-42. PubMed ID: 9007220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hierarchical structure of human megakaryocyte progenitor cells.
    Hoffman R; Murrav LJ; Young JC; Luens KM; Bruno E
    Stem Cells; 1996; 14 Suppl 1():75-81. PubMed ID: 11012205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.
    Gewirtz AM; Calabretta B; Rucinski B; Niewiarowski S; Xu WY
    J Clin Invest; 1989 May; 83(5):1477-86. PubMed ID: 2523411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle.
    Rosti V; Malabarba L; Ramajoli I; Casula S; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Salvaneschi L; Cazzola M
    Haematologica; 2000 Nov; 85(11 Suppl):18-25. PubMed ID: 11268318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
    Kato T; Horie K; Hagiwara T; Maeda E; Tsumura H; Ohashi H; Miyazaki H
    Exp Hematol; 1996 Aug; 24(10):1209-14. PubMed ID: 8765496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III).
    Han ZC; Bellucci S; Walz A; Baggiolini M; Caen JP
    Int J Cell Cloning; 1990 Jul; 8(4):253-9. PubMed ID: 2401804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.
    Orazi A; Cooper RJ; Tong J; Gordon MS; Battiato L; Sledge GW; Kaye JA; Kahsai M; Hoffman R
    Exp Hematol; 1996 Sep; 24(11):1289-97. PubMed ID: 8862439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents.
    Han ZC; Lu M; Li J; Defard M; Boval B; Schlegel N; Caen JP
    Blood; 1997 Apr; 89(7):2328-35. PubMed ID: 9116276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
    Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
    Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
    Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
    Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracil.
    Jansen R; Damia G; Usui N; Keller J; Futami H; Goey H; Back TT; Longo DL; Ruscetti FW; Wiltrout RH
    J Immunol; 1991 Nov; 147(10):3342-7. PubMed ID: 1940339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
    Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
    Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose granulocyte-colony stimulating factor (G-CSF) in vitro induces the growth of high proliferative potential colony forming cells (HPP-CFC) in patients undergoing blood stem cell mobilization.
    Perez-Oteyza J; Ramos P; Testa NG; Heinrichs B; Lopez-Jimenez J; Garcia-Laraña J; Odriozola J
    Exp Hematol; 1997 Jun; 25(6):516-20. PubMed ID: 9197330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
    LaIuppa JA; Papoutsakis ET; Miller WM
    Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.